2012-13922. Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)-Ethics Subcommittee (ES)

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the CDC announces the following meeting of the aforementioned subcommittee:

Time and Date: 9:30 a.m.-12:30 p.m. EDT, Friday, June 29, 2012.

Place: Teleconference.

Status: Open to the public, limited only by the availability of telephone ports. The public is welcome to participate during the public comment period. A public comment period is tentatively scheduled for 12 p.m.-12:15 p.m. To participate in the teleconference, please dial [phone] and enter code 4305992.

Purpose: The ES will provide counsel to the ACD, CDC, regarding a broad range of public health ethics questions and issues arising from programs, scientists and practitioners.

Matters To Be Discussed: Agenda items will include the following: Addition of ethics standards to the accreditation process for public health departments; ethical considerations relating to use of travel restrictions for the control of communicable diseases and possible revisions to CDC's standard operating procedures; progress on developing practical tools to assist state, tribal, local, and territorial health departments in their efforts to address public health ethics challenges; approaches for evaluating the impact of public health ethics; and strategies for increasing collaboration between public health ethics and public health law.

The agenda is subject to change as priorities dictate.

Contact Person for More Information: Drue Barrett, Ph.D., Designated Federal Officer, ACD, CDC-ES, 1600 Clifton Road NE., M/S D-50, Atlanta, Georgia 30333. Telephone: [phone]. Email: [e-mail].

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: June 4, 2012.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.